Aromatase transgenic upregulation modulates basal cardiac performance and the response to ischemic stress in male mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 9, 2014, Pages

  Bell, James R ^a   Bernasochi, Gabriel B ^a   Varma, Upasna ^a   Boon, Wah Chin ^a   Ellem, Stuart J ^b   Risbridger, Gail P ^b   Delbridge, Lea M D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aromatase; Arrhythmia; Contractile function; Estrogen; Ischemia reperfusion

Indexed keywords

AROMATASE; CALCIUM ION; ESTROGEN; PHOSPHOLAMBAN; PROTEIN KINASE B; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TESTOSTERONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM SIGNALING; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ENZYME PHOSPHORYLATION; FEMALE; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART STRESS; HEART VENTRICLE FIBRILLATION; HEART WEIGHT; ISCHEMIC HEART DISEASE; ISOLATED HEART; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SEX DIFFERENCE; UPREGULATION; VOLKMANN CONTRACTURE; WILD TYPE;

AROMATASE; ARRHYTHMIA; CONTRACTILE FUNCTION; ESTROGEN; ISCHEMIA/REPERFUSION;

ANIMALS; AROMATASE; ESTROGENS; FEMALE; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; SEX FACTORS; STRESS, PHYSIOLOGICAL; TESTOSTERONE; UP-REGULATION;

EID: 84900528545     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00012.2014     Document Type: Article

References (58)

1. Beitelshees AL, Johnson JA, Hames ML, Gong Y, Cooper-Dehoff RM, Wu J, Cresci S, Ma CX, Pepine CJ, Province MA, Spertus JA, McLeod HL. Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner. PLOS ONE 5: e15180, 2010.
2. Bell JR, Bernasochi GB, Varma U, Raaijmakers AJ, Delbridge LM. Sex and sex hormones in cardiac stress-mechanistic insights. J Steroid Biochem Mol Biol 137: 124-135, 2013.
3. 2+/calmodulin-dependent protein kinase inhibition suppresses post-ischemic arrhythmogenesis and mediates sinus bradycardic recovery in reperfusion. Int J Cardiol 159: 112-118, 2012.
4. Bell JR, Eaton P, Shattock MJ. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart. Clin Exp Pharmacol Physiol 35: 126-134, 2008.
5. Bell JR, Kennington E, Fuller W, Dighe K, Donoghue P, Clark JE, Jia LG, Tucker AL, Moorman JR, Marber MS, Eaton P, Dunn MJ, Shattock MJ. Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity. Am J Physiol Heart Circ Physiol 294: H613-H621, 2008.
6. 2+, sex and sex steroids. Clin Exp Pharmacol Physiol 38: 717-723, 2011.
7. Bell JR, Mellor KM, Wollermann AC, Ip WT, Reichelt ME, Meachem SJ, Simpson ER, Delbridge LM. Aromatase deficiency confers paradoxical postischemic cardioprotection. Endocrinology 152: 4937-4947, 2011.
8. Bell JR, Porrello ER, Huggins CE, Harrap SB, Delbridge LM. The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy. Am J Physiol Heart Circ Physiol 294: H1514-H1522, 2008.
9. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128: 191-227, 2010.
10. Broughton BR, Brait VH, Kim HA, Lee S, Chu HX, Gardiner-Mann CV, Guida E, Evans MA, Miller AA, Arumugam TV, Drummond GR, Sobey CG. Sex-dependent effects of G protein-coupled estrogen receptor activity on outcome after ischemic stroke. Stroke 45: 835-841, 2014.
11. Brown DA, Lynch JM, Armstrong CJ, Caruso NM, Ehlers LB, Johnson MS, Moore RL. Susceptibility of the heart to ischaemiareperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol 564: 619-630, 2005.
12. Callies F, Stromer H, Schwinger RH, Bolck B, Hu K, Frantz S, Leupold A, Beer S, Allolio B, Bonz AW. Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology 144: 4478-4483, 2003.
13. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, Schaefer E, Kajstura J, Anversa P, Sussman MA. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 88: 1020-1027, 2001.
14. Charlier TD, Cornil CA, Ball GF, Balthazart J. Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain. Biochim Biophys Acta 1800: 1094-1105, 2010.
15. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 83: 1215-1223, 1998.
16. 2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemiareperfusion injury. Am J Physiol Heart Circ Physiol 283: H481-H489, 2002.
17. 2+ handling and contractile function. Physiol Res 58: 293-297, 2009.
18. 2+]i in female rat cardiac myocytes. Clin Exp Pharmacol Physiol 30: 489-494, 2003.
19. 2+] in rat cardiomyocytes. Pflügers Arch 441: 709-716, 2001.
20. Deschamps AM, Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 297: H1806-H1813, 2009
21. Ellem SJ, Wang H, Poutanen M, Risbridger GP. Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol 175: 1187-1199, 2009.
22. + channels in the cardiac mitochondrial inner membrane. Circulation 110: 3100-3107, 2004.
23. Erickson JR, He BJ, Grumbach IM, Anderson ME. CaMKII in the cardiovascular system: sensing redox states. Physiol Rev 91: 889-915, 2011.
24. Farrell SR, Ross JL, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 299: H36-H45, 2010.
25. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor beta mediates gender differences in ischemia/ reperfusion injury. J Mol Cell Cardiol 38: 289-297, 2005.
26. Grohe C, Kahlert S, Lobbert K, Stimpel M, Karas RH, Vetter H, Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416: 107-112, 1997.
27. Haines CD, Harvey PA, Luczak ED, Barthel KK, Konhilas JP, Watson PA, Stauffer BL, Leinwand LA. Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology 153: 4470-4479, 2012.
28. Headrick JP. Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation. J Mol Cell Cardiol 30: 1415-1430, 1998.
29. Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol 39: 986-993, 1977.
30. Huggins CE, Bell JR, Pepe S, Delbridge LM. Benchmarking ventricular arrhythmias in the mouse-revisiting the 'Lambeth Conventions' 20 years on. Heart Lung Circ 17: 445-450, 2008.
31. Hunter JC, Kostyak JC, Novotny JL, Simpson AM, Korzick DH. Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKC, PKC, Akt, and GSK3. Am J Physiol Regul Integr Comp Physiol 292: R800-R809, 2007.
32. Jazbutyte V, Stumpner J, Redel A, Lorenzen JM, Roewer N, Thum T, Kehl F. Aromatase inhibition attenuates desflurane-induced preconditioning against acute myocardial infarction in male mouse heart in vivo. PLOS ONE 7: e42032, 2012.
33. Kohno H, Takahashi N, Shinohara T, Ooie T, Yufu K, Nakagawa M, Yonemochi H, Hara M, Saikawa T, Yoshimatsu H. Receptor-mediated suppression of cardiac heat-shock protein 72 expression by testosterone in male rat heart. Endocrinology 148: 3148-3155, 2007.
34. Kolodgie FD, Farb A, Litovsky SH, Narula J, Jeffers LA, Lee SJ, Virmani R. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol 29: 2403-2414, 1997.
35. Kuhar P, Lunder M, Drevensek G. The role of gender and sex hormones in ischemic-reperfusion injury in isolated rat hearts. Eur J Pharmacol 561: 151-159, 2007.
36. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res 106: 1681-1691, 2010.
37. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Warri A, Huhtaniemi I, Santti R, Makela S, Poutanen M. Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142: 2435-2442, 2001.
38. Li X, Strauss L, Makela S, Streng T, Huhtaniemi I, Santti R, Poutanen M. Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor. Am J Pathol 164: 1039-1048, 2004.
39. Liu A, Gao L, Kang S, Liu Y, Xu C, Sun H, Li D, Yan C. Testosterone enhances estradiol's cardioprotection in ovariectomized rats. J Endocrinol 212: 61-69, 2012.
40. Liu J, Tsang S, Wong TM. Testosterone is required for delayed cardioprotection and enhanced heat shock protein 70 expression induced by preconditioning. Endocrinology 147: 4569-4577, 2006.
41. Lizotte E, Grandy SA, Tremblay A, Allen BG, Fiset C. Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cell Physiol Biochem 23: 75-86, 2009.
42. Lu Z, Jiang YP, Wang W, Xu XH, Mathias RT, Entcheva E, Ballou LM, Cohen IS, Lin RZ. Loss of cardiac phosphoinositide 3-kinase p110 α results in contractile dysfunction. Circulation 120: 318-325, 2009.
43. Mellor KM, Bell JR, Young MJ, Ritchie RH, Delbridge LM. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol 50: 1035-1043, 2011.
44. Nam UH, Wang M, Crisostomo PR, Markel TA, Lahm T, Meldrum KK, Lillemoe KD, Meldrum DR. The effect of chronic exogenous androgen on myocardial function following acute ischemia-reperfusion in hosts with different baseline levels of sex steroids. J Surg Res 142: 113-118, 2007.
45. Parks RJ, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling. Pflügers Arch 465: 747-763, 2013.
46. 2+ channel blockade. Br J Pharmacol 149: 233-242, 2006.
47. Raddino R, Manca C, Poli E, Bolognesi R, Visioli O. Effects of 17-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther 281: 57-65, 1986.
48. Raddino R, Poli E, Pela G, Manca C. Action of steroid sex hormones on the isolated rabbit heart. Pharmacology 38: 185-190, 1989.
49. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5: 425-438, 2006.
50. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002.
51. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86: 225-230, 2003.
52. Sitzler G, Lenz O, Kilter H, La Rosee K, Bohm M. Investigation of the negative inotropic effects of 17-oestradiol in human isolated myocardial tissues. Br J Pharmacol 119: 43-48, 1996.
53. Sjogren L, Lagerquist M, Moverare-Skrtic S, Anderrson N, Windahl SH, Swanson C, Mohan S, Poutanen M, Ohlsson C. Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects. J Bone Miner Res 24: 1263-1270, 2009.
54. 2+ channel β1 subunit and reduced ischemia/reperfusion injury. Circ Res 98: 403-411, 2006.
55. Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 90: 9-17, 2011.
56. van Eickels M, Patten RD, Aronovitz MJ, Alsheikh-Ali A, Gostyla K, Celestin F, Grohe C, Mendelsohn ME, Karas RH. 17--estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J Am Coll Cardiol 41: 2084-2092, 2003.
57. Vila-Petroff M, Salas MA, Said M, Valverde CA, Sapia L, Portiansky E, Hajjar RJ, Kranias EG, Mundina-Weilenmann C, Mattiazzi A. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc Res 73: 689-698, 2007.
58. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 279: H2766-H2775, 2000.